ACV: Q4 FY16: $1.5M Q1 FY17: $2.3M Q2 FY17: $3.1M Q3 FY 17: $4.1M I think that's what the presentation is trying to say, i.e. sales is still accelerating..
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come